R Francavilla1, F Cristofori1, L Verzillo1, A Gentile1, S Castellaneta2, C Polloni3, V Giorgio4, E Verduci5, E DʼAngelo6, S Dellatte7, F Indrio1. 1. Interdisciplinary Department of Medicine-Pediatric Section, University of Bari, Bari, Italy. 2. Department of Pediatrics, San Paolo Hospital, Bari Italy. 3. Department of Pediatrics, Santa Maria del Carmine Hospital, Rovereto TN, Italy. 4. Department of Pediatrics, Catholic University, Rome, Italy. 5. Department of Pediatrics, University of Milan, S. Paolo Hospital, Milan, Italy. 6. Department of Pediatrics, Santa Maria Incoronata dell'Olmo Hospital. 7. Tandoi Group Factory, Corato, Italy.
Abstract
OBJECTIVES: Non-celiac gluten sensitivity (NCGS) is characterized by intestinal and extra-intestinal symptoms that are related to the ingestion of gluten in subjects who are not affected by either celiac disease (CD) or wheat allergy (WA). In this multicenter study, we aim for the first time to evaluate the prevalence of NCGS in pediatric subjects with chronic functional gastrointestinal symptoms associated with gluten ingestion using a double-blind placebo-controlled (DBPC) gluten challenge with crossover. METHODS: Among 1,114 children with chronic gastrointestinal symptoms (negative CD and WA), those exhibiting a positive correlation between symptoms and gluten ingestion were eligible for a diagnostic challenge including the following phases: run-in, open gluten-free diet (GFD) and DBPC crossover gluten challenge. Patients were randomized to gluten (10 g/daily) and placebo (rice starch) for 2 weeks each, separated by a washout week. The gluten challenge was considered positive in the presence of a minimum 30% decrease of global visual analogue scale between gluten and placebo. RESULTS: Out of 1,114 children, 96.7% did not exhibit any correlation with gluten ingestion. Thirty-six children were eligible; after the run-in and open GFD, 28 patients entered the gluten challenge. Eleven children (39.2%; 95% CI: 23.6-53.6%) tested positive. CONCLUSIONS: This is the first demonstration of the existence of NCGS in children that reinforce the need for a DBPC for the diagnosis as the diagnosis is ruled out in >60% of cases. The registration identifier in ClinicalsTrials.gov is NCT02431585.
RCT Entities:
OBJECTIVES: Non-celiac gluten sensitivity (NCGS) is characterized by intestinal and extra-intestinal symptoms that are related to the ingestion of gluten in subjects who are not affected by either celiac disease (CD) or wheatallergy (WA). In this multicenter study, we aim for the first time to evaluate the prevalence of NCGS in pediatric subjects with chronic functional gastrointestinal symptoms associated with gluten ingestion using a double-blind placebo-controlled (DBPC) gluten challenge with crossover. METHODS: Among 1,114 children with chronic gastrointestinal symptoms (negative CD and WA), those exhibiting a positive correlation between symptoms and gluten ingestion were eligible for a diagnostic challenge including the following phases: run-in, open gluten-free diet (GFD) and DBPC crossover gluten challenge. Patients were randomized to gluten (10 g/daily) and placebo (rice starch) for 2 weeks each, separated by a washout week. The gluten challenge was considered positive in the presence of a minimum 30% decrease of global visual analogue scale between gluten and placebo. RESULTS: Out of 1,114 children, 96.7% did not exhibit any correlation with gluten ingestion. Thirty-six children were eligible; after the run-in and open GFD, 28 patients entered the gluten challenge. Eleven children (39.2%; 95% CI: 23.6-53.6%) tested positive. CONCLUSIONS: This is the first demonstration of the existence of NCGS in children that reinforce the need for a DBPC for the diagnosis as the diagnosis is ruled out in >60% of cases. The registration identifier in ClinicalsTrials.gov is NCT02431585.
Authors: Pornthep Tanpowpong; Tristram R Ingham; Phillipa K Lampshire; Franca F Kirchberg; Michael J Epton; Julian Crane; Carlos A Camargo Journal: Arch Dis Child Date: 2011-11-10 Impact factor: 3.791
Authors: Antonio Carroccio; Pasquale Mansueto; Giuseppe Iacono; Maurizio Soresi; Alberto D'Alcamo; Francesca Cavataio; Ignazio Brusca; Ada M Florena; Giuseppe Ambrosiano; Aurelio Seidita; Giuseppe Pirrone; Giovanni Battista Rini Journal: Am J Gastroenterol Date: 2012-07-24 Impact factor: 10.864
Authors: Patricia A McGrath; Cheryl E Seifert; Kathy N Speechley; John C Booth; Larry Stitt; Margaret C Gibson Journal: Pain Date: 1996-03 Impact factor: 6.961
Authors: Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal Journal: Gut Date: 2012-06-22 Impact factor: 23.059